MSSV Stock Overview
Meso Numismatics, Inc. engages in the numismatic business in the United States and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Meso Numismatics, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.036 |
| 52 Week High | US$0.06 |
| 52 Week Low | US$0.0072 |
| Beta | 1.53 |
| 1 Month Change | -14.29% |
| 3 Month Change | 247.16% |
| 1 Year Change | 144.90% |
| 3 Year Change | -78.05% |
| 5 Year Change | -54.83% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| MSSV | US Specialty Retail | US Market | |
|---|---|---|---|
| 7D | 0% | -2.2% | -3.2% |
| 1Y | 144.9% | 7.3% | 19.3% |
Return vs Industry: MSSV exceeded the US Specialty Retail industry which returned 7.3% over the past year.
Return vs Market: MSSV exceeded the US Market which returned 19.3% over the past year.
Price Volatility
| MSSV volatility | |
|---|---|
| MSSV Average Weekly Movement | 63.5% |
| Specialty Retail Industry Average Movement | 6.9% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: MSSV's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine MSSV's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 1 | Dave Christensen | www.mesonumismatics.com |
Meso Numismatics, Inc. engages in the numismatic business in the United States and internationally. It sells its products through an online store, mesocoins.com. The company also provides CELLGENIC FLOW EXOSOMES; CELLGENIC MSC, which excretes growth factors, cytokines, and proteins for regeneration of tissue; CELLGENIC LUMA that is derived from human umbilical cord mesenchymal stem cells, including potent growth factors, peptides, coenzymes, minerals, amino acids, vitamins, and UV radiation reducing agents for skin revitalization; VITANOVAS that offers in-home treatments to patients in need of immune modulation to help fight infections, viruses, and diseases; GCELL RESTORE, a closed-system medical device to harness the natural and restorative capabilities of adipose tissue; CELLGENIC SVF, an isolation kit system that has the ingredients and consumables for the extraction of adipose-derived stem cells from fat; CELLGENIC BONE MARROW; and CELLGENIC Platelet Rich Plasma for healing and reducing inflammation.
Meso Numismatics, Inc. Fundamentals Summary
| MSSV fundamental statistics | |
|---|---|
| Market cap | US$449.78k |
| Earnings (TTM) | -US$9.81m |
| Revenue (TTM) | US$2.41m |
0.2x
P/S Ratio0.0x
P/E RatioIs MSSV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MSSV income statement (TTM) | |
|---|---|
| Revenue | US$2.41m |
| Cost of Revenue | US$734.29k |
| Gross Profit | US$1.68m |
| Other Expenses | US$11.49m |
| Earnings | -US$9.81m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.79 |
| Gross Margin | 69.53% |
| Net Profit Margin | -407.21% |
| Debt/Equity Ratio | -81.0% |
How did MSSV perform over the long term?
See historical performance and comparison